Their job is to maximise shareholder value, not do whatever excites themselves the most, something I am sure they are focused on. I am also sure if it moves into 'boring' phase, he/they will find a suitable replacement that finds transitioning NEU to be a major player, and the 2nd largest biotech stock on the ASX, exciting.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)